title: Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension.
authors.affiliation: From Pulmonary and Critical Care Medicine, Center for Pulmonary Heart Disease (A.B.W.), Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA (A.B.W.); and Pulmonary Hypertension Center, Boston Medical Center, Boston University School of Medicine, Boston, MA (H.W.F.). abwaxman@partners.org.
authors.forename: Aaron B
authors.initials: AB
authors.lastname: Waxman
authors.affiliation: From Pulmonary and Critical Care Medicine, Center for Pulmonary Heart Disease (A.B.W.), Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA (A.B.W.); and Pulmonary Hypertension Center, Boston Medical Center, Boston University School of Medicine, Boston, MA (H.W.F.).
authors.forename: Harrison W
authors.initials: HW
authors.lastname: Farber
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D003952:Diagnostic Imaging / Q000379:methods; D023381:Endpoint Determination / Q000379:methods*; D005080:Exercise Test / Q000379:methods; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D018570:Risk Assessment
keywords: clinical trial; hypertension, pulmonary; patient outcome assessment; performance measure